Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Outstanding Supervisory Board Backs Innovative Life Sciences Company Newtricious


News provided by

UBM Live and Newtricious

28 May, 2013, 11:15 GMT

Share this article

Share toX

Share this article

Share toX

OIRLO, Netherlands, May 28, 2013 /PRNewswire/ --

The General Meeting of Shareholders of Newtricious B.V. has recently appointed its first Supervisory Board.

Newtricious is a life sciences company which produces specialized nutrition that enhances people's health and well-being. Newtricious develops these products based on natural ingredients derived from e.g. eggs.  These products can contribute to the preservation of visual function in individuals with dry macular degeneration (age-related blindness), the number 1 eye disease in the Western world, for which no treatment is available yet.

In addition, Newtricious develops food products based on e.g. bio-active peptides (derived from eggs and other sources of protein) aimed at preventing type 2 diabetes and heart and vascular diseases in people at increased risk.

In light of its expertise, the Supervisory Board will be closely involved in strategic planning and direction of scientific research and corporate policy and will, from within its network, offer Newtricious support with regard to the internationalisation of product concepts.

The Supervisory Board seats:

  • Ir. Jan Zuidam (Chairman)
  • Prof. Dr. Wim van Gelder
  • Ir. Jan van der Hoeven
  • Drs. Susan Swarte RC
  • Prof. Ir. Ena Vôute

Jan Zuidam (Chairman) started his career at DSM Research in Geleen in 1973. Between 1977 and 1983, he held various positions among which Head of Purchasing for the DSM Organic Products Group and Head of Production of the Special Products business unit. In 1987, Jan Zuidam was appointed Director of the DSM acquisition DSM Andeno. In 1990, he became Director Corporate Strategy of DSM. In 1992, Jan Zuidam returned to DSM Research as Director. In 1998, he joined the Managing Board of Directors. From 2001 until the day of his retirement, on 1 January 2010, Jan Zuidam was Vice-Chairman of the Managing Board.  In 2010/11, he chaired the Brainport 2020 initiative. He currently is Chairman of the Limburgse Werkgevers Vereniging [Limburg Employers Association] LWV.

Professor Wim van Gelder is an internationally renowned scientist and R&D manager who is passionate about applying science to society. Author of numerous scientific and application-oriented publications, Wim van Gelder also has a seat on a number of important national and international advisory committees. As Director of the former Numico Research group, he contributed immensely to the professionalization of this organisation. Under his leadership, the company grew into a leading international research organisation. One example of this is the pioneering biomedical research that resulted in products for infants, diabetics and Alzheimer's patients. Furthermore, he held the positions of Director Technology Policy at VNO-NCW, Dean at the Eindhoven University of Technology, Senior Vice-President Research at Numico and Senior Vice-President Scientific Affairs at Danone.

Jan van der Hoeven obtained his degree in Environmental Hygiene with honours in 1978 and started his career as scientist at the Wageningen University Toxicology Department. In 1984, he won the European Environmental Mutagen Society EEMS Award for young researchers for his research on the link between diet & cancer. In 1983, he set up his own company NOTOX with 2 other partners. In 2003, Jan van der Hoeven won the Wageningen University Fund Entrepreneurship Award. He set up VitrOmics, a company that specializes in 'genomics' in 2004. Jan van der Hoeven furthermore invests in and supports numerous starting life sciences companies via the private incubator WesterToren Innovation Centre.

Susan Swarte has extensive experience in financial and strategic management. She worked for Unilever and Numico (presently Danone), two large, international and listed companies, where she was in charge of finance, logistics and reporting in the Netherlands and in China. She has been CFO of the Dutch biopharmaceutical company OctoPlus N.V. since 2009.

Ena Vôute studied industrial design at TU Delft. During the nineties, Ena Vôute worked for Unilever, where she developed global brand and marketing strategies for products like Magnum and a range of margarine products. At the start of this century she was appointed Marketing Director of the new financial product comparison website Independer and worked as Innovation Consultant at Altuïtion. Over the past nine years she held a number of global positions at Philips Consumer Lifestyle and Lighting. She was Category Manager Beauty and Vitalight at Philips Consumer Lifestyle, CEO Global Lighting and CMO Consumer Luminaires at Philips Lighting. Since 2012, she has been Head of the Industrial Design Department at the Delft University of Technology.

--------------------------------------------------------------------------------------------------------------------------------------

Newtricious
Newtricious was founded in 2006 with the aim to develop innovative food ingredients, which contribute to a better health and well-being. The company builds strong consortia of scientific institutes and innovative companies (both SMEs and multinationals), in which it has a connecting and steering role. The goal is to develop, jointly with other parties, a new generation of active food ingredients and products that can contribute to a better quality of life.

Scientific principles from the pharma industry are adhered in order to develop food products with a health claim in order to set new standards for legislation and scientific quality

Manufacturing is being performed by partners or subcontractors. The earning model includes a strong package of patents and market registrations that enable commercial partners to reach a large number of individuals in the risk groups with Newtricious' promising products.

For further information about the content of this press release,  please contact: Jos Nelissen, CEO Newtricious, +31(0)478-578702, e-mail: jos.nelissen@newtricious.nl

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.